Preventive drug treatmenta in patients aged ≥60 years with a history of myocardial infarction, depending on age group, at three time points.b
| 2000, total n = 232 | 2004, total n = 266 | 2007, total n = 302 | |
|---|---|---|---|
| Age 60–69 years | n = 99 | n = 118 | n = 122 |
| 3–4 drugs | 38 (29 to 48) | 59 (50 to 68) | 70 (62 to 78) |
| Type of drug | |||
| Antithrombotics | 78 (69 to 85) | 83 (75 to 89) | 89 (83 to 94) |
| Statins | 56 (46 to 65) | 78 (70 to 84) | 77 (69 to 84) |
| Beta-blockers | 42 (33 to 52) | 53 (44 to 62) | 63 (54 to 71) |
| ACE inhibitors | 28 (20 to 38) | 38 (30 to 47) | 57 (48 to 65) |
| Age 70–79 years | n = 80 | n = 91 | n = 108 |
| 3–4 drugs | 34 (24 to 45) | 49 (39 to 60) | 55 (45 to 64) |
| Type of drug | |||
| Antithrombotics | 85 (76 to 91) | 86 (77 to 91) | 86 (78 to 91) |
| Statins | 46 (36 to 57) | 67 (57 to 76) | 73 (64 to 81) |
| Beta-blockers | 35 (25 to 46) | 51 (40 to 61) | 56 (47 to 65) |
| ACE inhibitors | 35 (25 to 46) | 30 (21 to 40) | 39 (30 to 48) |
| Age ≥80 years | n = 53 | n = 57 | n = 72 |
| 3–4 drugs | 23 (13 to 36) | 40 (29 to 53) | 50 (39 to 61) |
| Type of drug | |||
| Antithrombotics | 83 (71 to 91) | 89 (79 to 95) | 89 (80 to 94) |
| Statins | 19 (11 to 31) | 44 (32 to 57) | 57 (45 to 68) |
| Beta-blockers | 42 (29 to 55) | 51 (38 to 63) | 50 (39 to 61) |
| ACE inhibitors | 28 (18 to 42) | 42 (30 to 55) | 42 (31 to 53) |